CNM-Au8 Raises Cellular Energy in Brains of Patients in REPAIR-PD Trial

CNM-Au8 Raises Cellular Energy in Brains of Patients in REPAIR-PD Trial

302032

CNM-Au8 Raises Cellular Energy in Brains of Patients in REPAIR-PD Trial

Clene Nanomedicine‘s investigational oral Parkinson’s treatment, CNM-Au8, safely and significantly increased energy metabolism in the brains of patients taking part in the Phase 2 REPAIR clinical trials, top-line results show. Greater energy metabolism is expected to lower oxidative stress in the brain, making more energy available to protect and preserve the dopamine-producing neurons that decay over the course of the illness. Nerve cells are known to require large amounts of energy. These single-site, pilot trials — REPAIR-PD…

You must be logged in to read/download the full post.